Bennett JJ - Search Results

1

Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer.

Delman KA, Zager JS, Bennett JJ, Malhotra S, Ebright MI, McAuliffe PF, Halterman MW, Federoff HJ, Fong Y. Delman KA, et al. Among authors: bennett jj. Ann Surg. 2002 Sep;236(3):337-42; discussion 342-3. doi: 10.1097/00000658-200209000-00010. Ann Surg. 2002. PMID: 12192320 Free PMC article.

2

Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas.

Malhotra S, Kim T, Zager J, Bennett J, Ebright M, D'Angelica M, Fong Y. Malhotra S, et al. Surgery. 2007 Apr;141(4):520-9. doi: 10.1016/j.surg.2006.10.010. Epub 2007 Feb 14. Surgery. 2007. PMID: 17383529 Free PMC article.

3

Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer.

Bennett JJ, Delman KA, Burt BM, Mariotti A, Malhotra S, Zager J, Petrowsky H, Mastorides S, Federoff H, Fong Y. Bennett JJ, et al. Cancer Gene Ther. 2002 Nov;9(11):935-45. doi: 10.1038/sj.cgt.7700510. Cancer Gene Ther. 2002. PMID: 12386832

4

Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy.

Delman KA, Bennett JJ, Zager JS, Burt BM, McAuliffe PF, Petrowsky H, Kooby DA, Hawkins WG, Horsburgh BC, Johnson P, Fong Y. Delman KA, et al. Among authors: bennett jj. Hum Gene Ther. 2000 Dec 10;11(18):2465-72. doi: 10.1089/10430340050207957. Hum Gene Ther. 2000. PMID: 11119418

5

Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer.

Bennett JJ, Malhotra S, Wong RJ, Delman K, Zager J, St-Louis M, Johnson P, Fong Y. Bennett JJ, et al. Ann Surg. 2001 Jun;233(6):819-26. doi: 10.1097/00000658-200106000-00012. Ann Surg. 2001. PMID: 11371740 Free PMC article.

6

Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.

Zager JS, Delman KA, Malhotra S, Ebright MI, Bennett JJ, Kates T, Halterman M, Federoff H, Fong Y. Zager JS, et al. Among authors: bennett jj. Mol Med. 2001 Aug;7(8):561-8. Mol Med. 2001. PMID: 11591892 Free PMC article.

7

Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207).

Bennett JJ, Adusumilli P, Petrowsky H, Burt BM, Roberts G, Delman KA, Zager JS, Chou TC, Fong Y. Bennett JJ, et al. FASEB J. 2004 Jun;18(9):1001-3. doi: 10.1096/fj.02-1080fje. Epub 2004 Apr 1. FASEB J. 2004. PMID: 15059970

8

Effect of murine liver cell proliferation on herpes viral behavior: implications for oncolytic viral therapy.

Delman KA, Zager JS, Bhargava A, Petrowsky H, Malhotra S, Ebright MI, Bennett JJ, Gusani NJ, Kooby DA, Roberts GD, Fong Y. Delman KA, et al. Among authors: bennett jj. Hepatology. 2004 Jun;39(6):1525-32. doi: 10.1002/hep.20198. Hepatology. 2004. PMID: 15185293

9

Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer.

Bennett JJ, Kooby DA, Delman K, McAuliffe P, Halterman MW, Federoff H, Fong Y. Bennett JJ, et al. J Mol Med (Berl). 2000;78(3):166-74. doi: 10.1007/s001090000092. J Mol Med (Berl). 2000. PMID: 10868479

10

Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.

Wong RJ, Patel SG, Kim S, DeMatteo RP, Malhotra S, Bennett JJ, St-Louis M, Shah JP, Johnson PA, Fong Y. Wong RJ, et al. Among authors: bennett jj. Hum Gene Ther. 2001 Feb 10;12(3):253-65. doi: 10.1089/10430340150218396. Hum Gene Ther. 2001. PMID: 11177562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters